Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivascardiology

Paeds Vivas · cardiology

Pulmonary hypertension in children — branching viva

Branching viva on pulmonary hypertension in children: the haemodynamic definition, the WHO classification, the echocardiographic and catheter-based diagnosis, the three drug pathways, the Eisenmenger threshold, and the surgical escalations.

branching clinical structured oral
On this page & tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
An eight-year-old child collapses while running at school and is found to have a loud, palpable pulmonary component of the second heart sound. The examiner asks: what is your differential, how do you define and confirm pulmonary hypertension, what are the five WHO groups, why does the right ventricle decide the prognosis, and what are the three drug pathways and their targets — then branches to the vasoreactivity test, the Eisenmenger threshold, the bronchopulmonary-dysplasia form, and finally the surgical escalations of septostomy, the Potts shunt, and transplantation.

Branch 1 — Definition and classification

The candidate opens by defining pulmonary hypertension as a mean pulmonary artery pressure above twenty at cardiac catheterisation, with pulmonary arterial hypertension adding a raised resistance and a normal wedge pressure. They then name the five WHO groups and explain why congenital heart disease and bronchopulmonary dysplasia dominate the paediatric caseload. [3] [2]

Branch 2 — Diagnosis and the role of the catheter

The examiner probes why echocardiography is first-line but the catheter is the gold standard. The candidate explains that the echo estimates the pressure from the tricuspid regurgitation velocity and assesses the right ventricle, while the catheter confirms the diagnosis, measures the wedge pressure and the indexed resistance, and tests for vasoreactivity with inhaled nitric oxide. They stress that the wedge pressure is the safeguard against treating left heart disease. [1] [4]

Branch 3 — The three drug pathways and risk stratification

The candidate explains the three imbalanced endothelial pathways — nitric oxide and prostacyclin falling while endothelin rises — and the matching drugs: phosphodiesterase-5 inhibitors, prostacyclin analogues, and endothelin receptor antagonists. They describe the risk stratification into low, intermediate, and high risk, and why the high-risk child with right ventricular failure is escalated to parenteral prostacyclin. [5] [10]

Branch 4 — The Eisenmenger threshold

The examiner branches to the teenager with the late-repaired ventricular septal defect and the fixed resistance. The candidate explains that the catheter, not the echo, decides operability, that repairing a shunt above the threshold removes the pop-off and worsens the failure, and that the Eisenmenger physiology is irreversible. They outline the management with targeted therapy and the avoidance of pregnancy. [8] [5]

Branch 5 — Surgical escalation

The final branch covers the refractory child. The candidate describes the atrial septostomy as a pop-off that decompresses the right ventricle, the Potts shunt as reserved for the suprasystemic idiopathic form, and lung transplantation as the final option. They close on the principle that the right ventricle, not the pressure number, decides the prognosis. [4] [2]

References

  1. [1]Abman SH, Hansmann G, Archer SL, et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation, 2015.PMID 26534956
  2. [2]Rosenzweig EB, Abman SH, Adatia I, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J, 2019.PMID 30545978
  3. [3]Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J, 2019.PMID 30545968
  4. [4]Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension. J Heart Lung Transplant, 2019.PMID 31495407
  5. [5]Ivy DD, Abman SH, Barst RJ, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol, 2013.PMID 24355636
  6. [8]Arvanitaki A, Gatzoulis MA, Opotowsky AR, et al. Eisenmenger Syndrome: JACC State-of-the-Art Review. J Am Coll Cardiol, 2022.PMID 35331414
  7. [10]Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation, 2012.PMID 22128226